Stockreport

Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs [Yahoo! Finance]

Wells Fargo & Company  (WFC) 
Last wells fargo & company earnings: 4/14 07:46 am Check Earnings Report
US:NYSE Investor Relations: wellsfargo.com/about/investor-relations
PDF Proceeds to support ongoing mid- to late-stage clinical development programs for Company's lead I&I product candidate, obexelimab WALTHAM, Mass., May 07, 2024 (GLOBE [Read more]